Sequenom Overview

  • Founded
  • 1994
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 434
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $371M
Latest Deal Amount

Sequenom General Information

Description

Provider of genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company provides nucleic acid analysis platform that measures genetic target material and variations.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Monitoring Equipment
Primary Office
  • 3595 John Hopkins Court
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sequenom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Merger/Acquisition 07-Sep-2016 $371M 00000 00000 Completed Profitable
17. Debt Refinancing 18-Jun-2015 0000 00000 Completed Profitable
16. Debt - General 20-Sep-2012 00000 00000 Completed Profitable
15. 2PO 25-Jan-2012 0000 00000 Completed Profitable
14. Debt - General 02-Jun-2011 0000 00000 Completed Profitable
13. PIPE 21-May-2010 000.00 00000 Completed Profitable
12. PIPE 23-Dec-2009 00.000 00000 Completed Profitable
11. PIPE 09-Mar-2009 00.000 00000 Completed Profitable
10. PIPE 19-Nov-2008 $3.6M $247M Completed Profitable
9. Secondary Transaction - Open Market 01-Aug-2008 $244M Completed Profitable
To view Sequenom’s complete valuation and funding history, request access »

Sequenom Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company prov
Monitoring Equipment
San Diego, CA
434 As of 2015
00000
0000 0000-00-00
000000&0 00000

00000000

t, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000000000 000000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

0000000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud ex
0000000000 000000000
Irvine, CA
000 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sequenom Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Veracyte Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
0000000 Private Equity-Backed Irvine, CA 000 00000 000000000 - 00000
000000000000 Formerly VC-backed Carlsbad, CA 000 000.00 000000&0 000.00
To view Sequenom’s complete competitors history, request access »

Sequenom Executive Team (16)

Name Title Board Seat Contact Info
Dirk van den Boom Ph.D President, Chief Executive Officer, Board Member, Chief Scientific & Chief Strategy Officer
Carolyn Beaver Chief Financial Officer & Senior Vice President
Bill Bowen Senior Vice President & General Counsel
Daniel Grosu MD Senior Vice President & Chief Medical Officer
Michael Monko Senior Vice President
You’re viewing 5 of 16 executive team members. Get the full list »

Sequenom Board Members (10)

Name Representing Role Since
Catherine Mackey Ph.D Self Board Member 000 0000
Charles Slacik Sequenom Director 000 0000
David Pendarvis Sequenom Director 000 0000
Dirk van den Boom Ph.D Sequenom President, Chief Executive Officer, Board Member, Chief Scientific & Chief Strategy Officer 000 0000
John Fazio Self Director 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Sequenom Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sequenom Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Comvest Partners PE/Buyout Minority 000 0000 000000 0
Delaware Crossing Investor Group Angel Group Minority 000 0000 000000 0
Fort Mason Capital PE/Buyout Minority 000 0000 000000 0
Global Life Science Ventures Venture Capital Minority 000 0000 000000 0
Haspa BGM PE/Buyout Majority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

Sequenom Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 27-Jan-2009 000000000000000000 Biotechnology 00000 000000 00.0
Sequenom Center for Molecular Medicine 17-Nov-2008 Merger/Acquisition 000 Laboratory Services (Healthcare)
To view Sequenom’s complete acquisitions history, request access »